Cargando…

Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy

Hepatocellular carcinoma (HCC), one of the most malignant tumors, is characterized by its stubborn immunosuppressive microenvironment. As one of the main members of the tumor microenvironment (TME) of HCC, tumor-associated macrophages (TAMs) play a critical role in its occurrence and development, in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Hongyu, Peng, Xueqiang, Yang, Shuo, Li, Xinyu, Huang, Mingyao, Wei, Shibo, Zhang, Sheng, He, Guangpeng, Liu, Jiaxing, Fan, Qing, Yang, Liang, Li, Hangyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931715/ https://www.ncbi.nlm.nih.gov/pubmed/36792608 http://dx.doi.org/10.1038/s41420-023-01356-7

Ejemplares similares

Extracellular vesicle PD-L1 in reshaping tumor immune microenvironment: biological function and potential therapy strategies
por: Liu, Jiaxing, et al.
Publicado: (2022)

The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders
por: Zhang, Sheng, et al.
Publicado: (2022)

Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications
por: He, Guangpeng, et al.
Publicado: (2022)

Extracellular vesicle-cell adhesion molecules in tumours: biofunctions and clinical applications
por: Lin, Weikai, et al.
Publicado: (2023)

CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma
por: Li, Bowen, et al.
Publicado: (2021)

LINC00511 drives invasive behavior in hepatocellular carcinoma by regulating exosome secretion and invadopodia formation
por: Peng, Xueqiang, et al.
Publicado: (2021)

Targeting tumor innervation: premises, promises, and challenges
por: Li, Xinyu, et al.
Publicado: (2022)

Mesenchymal/stromal stem cells: necessary factors in tumour progression
por: Li, Xinyu, et al.
Publicado: (2022)

Autonomous glucose metabolic reprogramming of tumour cells under hypoxia: opportunities for targeted therapy
por: Huang, Mingyao, et al.
Publicado: (2020)

Crosstalk between autophagy and CSCs: molecular mechanisms and translational implications
por: Li, Dai, et al.
Publicado: (2023)

Rab GTPases: Central Coordinators of Membrane Trafficking in Cancer
por: Jin, Hongyuan, et al.
Publicado: (2021)

Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma
por: Yang, Liang, et al.
Publicado: (2019)

MicroRNA-375 Targets ATG14 to Inhibit Autophagy and Sensitize Hepatocellular Carcinoma Cells to Sorafenib
por: Yang, Shuo, et al.
Publicado: (2020)

Focus on the morphogenesis, fate and the role in tumor progression of multivesicular bodies
por: Peng, Xueqiang, et al.
Publicado: (2020)

Immunotherapy of hepatocellular carcinoma: recent progress and new strategy
por: Li, Jiarui, et al.
Publicado: (2023)

From macrophage biology to macrophage-based cellular immunotherapies
por: Mass, Elvira, et al.
Publicado: (2021)

Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma
por: Dai, Xiaomeng, et al.
Publicado: (2021)

Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma
por: Zheng, Yi, et al.
Publicado: (2019)

Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
por: Zhong, Cheng, et al.
Publicado: (2021)

Tumor-associated macrophage-related strategies for glioma immunotherapy
por: Tang, Fansong, et al.
Publicado: (2023)

Immunotherapies for advanced hepatocellular carcinoma
por: Sun, Li-Yang, et al.
Publicado: (2023)

Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma
por: Xing, Rui, et al.
Publicado: (2021)

Mechanisms and Clinical Trials of Hepatocellular Carcinoma Immunotherapy
por: Huang, Shao-Li, et al.
Publicado: (2021)

Macrophage-based Cell Strategies: A Novel Approach in Immunotherapy
por: Vinchi, Francesca
Publicado: (2022)

Transforming growth factor-beta1 suppresses hepatocellular carcinoma proliferation via activation of Hippo signaling
por: Zhang, Xiaodong, et al.
Publicado: (2017)

PIM2 Expression Induced by Proinflammatory Macrophages Suppresses Immunotherapy Efficacy in Hepatocellular Carcinoma
por: Wang, Jun-Cheng, et al.
Publicado: (2022)

Bibliometric study of immunotherapy for hepatocellular carcinoma
por: Li, Zhiyi, et al.
Publicado: (2023)

miR-425 regulates lipophagy via SIRT1 to promote sorafenib resistance in liver cancer
por: Sun, Gongping, et al.
Publicado: (2021)

Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations
por: Xie, Yingjun, et al.
Publicado: (2018)

Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy
por: Xu, Shumin, et al.
Publicado: (2023)

Mesoporous Silica Nanoparticles for Potential Immunotherapy of Hepatocellular Carcinoma
por: Wu, Han, et al.
Publicado: (2021)

Application of Immunotherapy in Hepatocellular Carcinoma
por: Miao, Lele, et al.
Publicado: (2021)

Stereotactic Radiotherapy for Hepatocellular Carcinoma, Radiosensitization Strategies and Radiation-Immunotherapy Combination
por: Pérez-Romasanta, Luis A., et al.
Publicado: (2021)

An Insight into the Novel Immunotherapy and Targeted Therapeutic Strategies for Hepatocellular Carcinoma and Cholangiocarcinoma
por: Trifylli, Eleni-Myrto, et al.
Publicado: (2022)

Editorial: Immunotherapy in Hepatocellular Carcinoma
por: Li, Bin, et al.
Publicado: (2021)

Four-Pyroptosis Gene-Based Nomogram as a Novel Strategy for Predicting the Effect of Immunotherapy in Hepatocellular Carcinoma
por: Li, Ning, et al.
Publicado: (2022)

Nanoengineered targeting strategy for cancer immunotherapy
por: Yin, Wei-min, et al.
Publicado: (2020)

Design, Synthesis, and Biological Evaluation of Pyrano[2,3-c]-pyrazole–Based RalA Inhibitors Against Hepatocellular Carcinoma
por: Wang, Yuting, et al.
Publicado: (2021)

Cellular backpacks for macrophage immunotherapy
por: Shields, C. Wyatt, et al.
Publicado: (2020)

Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1
por: Yang, Jing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5jsvpc043hf6kbpmefh59db56h